Analysts’ Viewpoint on Market Scenario
Several multinational companies and emerging players in the sleep apnea devices market have already started re-evaluating their supply chains and in the process of shuffling their business operations to reduce concentration in a handful of countries during the ongoing COVID-19 pandemic. However, lack of insurance coverage for OSA and its related therapeutic & diagnostic machines and devices are affecting market growth in developing economies such as India. Hence, med-tech companies in the sleep apnea devices business should invest in marketing and advertising to increase the acceptance of these devices among patients. Such trends will encourage insurance companies to provide health coverage for sleep apnea and related comorbidities including OSA.
Key players in the global sleep apnea devices market are engaged in meeting regulatory approvals, launching technologically advanced products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the market for sleep apnea devices. Business expansion strategies adopted by players operating in the global market are innovating in 3D printed parts used to convert BiPAP (Bilevel Positive Airway Pressure) machines, generally used to treat sleep apnea or COPD, into ventilators.
Companies are entering into collaboration agreements to bring obstructive sleep apnea (OSA) treatment products directly to customers through sleep clinics in the U.S. They are introducing customizable oral appliance therapy devices, which hold potential as an alternative to CPAP (continuous positive airway pressure) therapy in the U.S.
Telehealth and eHealth mobile apps are anticipated to transform the sleep apnea devices market post the COVID-19 pandemic period. However, participants in the market are addressing disruption for sales since elective medical procedures have been postponed indefinitely. Hence, companies are taking data-driven decisions to map volatile demand trends for sleep apnea devices.
Domestic and global companies are in the midst of rapid shifts in supply chain planning, operations, and inventory management to address the impact of the pandemic. Nevertheless, companies are taking advantage of government stimulus packages to stay financially afloat. The demand for sleep apnea devices is projected to increase at a sluggish pace, due to the lockdown being enforced in most countries.
The most common treatment option for people with sleep apnea is CPAP devices. These machines are available in various sizes and styles. The price varies depending on the brand, type, and features. However, a CPAP machine can cost anywhere from US$ 250 to US$ 1,000 or more at retail. This is hampering the market growth. Hence, companies should partner with experts to innovate devices that are affordable.
On the other hand, in emerging markets such as India, the lack of medical coverage provided by public or private insurance companies tends to restrain market growth in the region. The dearth of awareness about obstructive sleep apnea in emerging countries is expected to affect market growth during the forecast period. Hence, companies should focus on marketing sleep apnea devices to increase their acceptance, which, in turn, will encourage insurance companies to provide coverage for health issues pertaining to the OSA.
Sleep disorders, including sleep apnea, have emerged as a major public health concern in the U.S. Sleep apnea affects an estimated 22 million people in the U.S., with 80% of moderate and severe obstructive sleep apnea cases going undiagnosed. This is fueling the need for advertising on sleep apnea devices to make people aware of the serious health risks of OSA.
OSA, which accounts for the majority of cases, can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems if left untreated. It is linked to type 2 diabetes and depression and is a factor in a number of traffic accidents and accidents involving heavy machinery due to the persistent drowsiness experienced by many OSA patients before the disease is diagnosed and treated. Thus, med-tech companies in the sleep apnea devices market should capitalize on this opportunity to bolster manufacturing capabilities to increase the availability of machines.
Obstructive sleep apnea is a prevalent disease wherein people continuously halt or reduce their breathing while sleeping. This leads to restless, fragmented sleep, which could cause symptoms such as morning headaches and daytime lethargy.
OSA affects people of all ages; however, it is more common in people over the age of 60. The precise incidence is unknown; however, it is thought to be between 2% and 14%. Obstructive sleep apnea is linked to a number of health problems, including hypertension, coronary artery disease, cardiac arrhythmias, and depression. Obesity, one of the major sleep apnea risk factors, is on the rise and contributes to the increase in the prevalence of sleep apnea. Such trends are translating into revenue opportunities for med-tech companies in the sleep apnea devices business.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 7 Bn |
|
Market Forecast Value in 2028 |
US$ 14.7 Bn |
|
Growth Rate (CAGR) |
8.5% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Sleep Apnea Devices Market – Segmentation
| Diagnostic Device |
|
| Therapeutic Device |
|
| Region |
|
The global market for Sleep apnea devices is expected to reach the value of US$ 14.7 Bn by the end of 2028
The market for sleep apnea devices is estimated to expand at a CAGR of 8.5% from 2021 to 2028
The sleep apnea devices market is driven by a rise in demand for home sleep apnea tests (HSATs), an increase in the need for diagnostic tests, and high adoption of sleep apnea devices
The polysomnography (PSG) devices segment accounted for a major share of the global sleep apnea devices market
Key players in the global market include ResMed, Inc., BMC Medical Co., Ltd., Braebon Medical Corporation, Compumedics Limited, Devilbiss Healthcare LLC, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sleep Apnea Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sleep Apnea Devices Market Analysis and Forecast, 2017–2028
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemics Impact on Industry
6. Global Sleep Apnea Devices Market Analysis and Forecast, by Diagnostic Device
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Diagnostic Device, 2017–2028
6.3.1. Actigraphy Systems
6.3.2. Polysomnography (PSG) Devices
6.3.3. Respiratory Polygraph
6.3.4. Single-channel Screening Devices (pulse oximeters)
6.4. Market Attractiveness Analysis, by Diagnostic Device
7. Global Sleep Apnea Devices Market Analysis and Forecast, by Therapeutic Device
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapeutic Device, 2017–2028
7.3.1. Airway Clearance Systems
7.3.2. Adaptive Servo-Ventilation (ASV)
7.3.3. Positive Airway Pressure (PAP) Devices
7.3.4. Oral Appliances
7.3.5. Oxygen Devices
7.3.6. Others
7.4. Market Attractiveness Analysis, by Therapeutic Device
8. Global Sleep Apnea Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Sleep Apnea Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Diagnostic Device, 2017–2028
9.2.1. Actigraphy Systems
9.2.2. Polysomnography (PSG) Device
9.2.3. Respiratory Polygraph
9.2.4. Single-Channel Screening Devices (pulse oximeters)
9.3. Market Value Forecast, by Therapeutic Device, 2017–2028
9.3.1. Airway Clearance Systems
9.3.2. Adaptive Servo-Ventilation (ASV)
9.3.3. Positive Airway Pressure (PAP) Devices
9.3.4. Oral Appliances
9.3.5. Oxygen Devices
9.3.6. Others
9.4. Market Value Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Diagnostic Device
9.5.2. By Therapeutic Device
9.5.3. By Country
10. Europe Sleep Apnea Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Device, 2017–2028
10.2.1. Actigraphy Systems
10.2.2. Polysomnography (PSG) Devices
10.2.3. Respiratory Polygraph
10.2.4. Single-Channel Screening Devices (pulse oximeters)
10.3. Market Value Forecast, by Therapeutic Device, 2017–2028
10.3.1. Airway Clearance Systems
10.3.2. Adaptive Servo-Ventilation (ASV)
10.3.3. Positive Airway Pressure (PAP) Devices
10.3.4. Oral Appliances
10.3.5. Oxygen Devices
10.3.6. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Diagnostic Device
10.5.2. By Therapeutic Device
10.5.3. By Country/Sub-region
11. Asia Pacific Sleep Apnea Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Device, 2017–2028
11.2.1. Actigraphy Systems
11.2.2. Polysomnography (PSG) Devices
11.2.3. Respiratory Polygraph
11.2.4. Single-Channel Screening Devices (pulse oximeters)
11.3. Market Value Forecast, by Therapeutic Device, 2017–2028
11.3.1. Airway Clearance Systems
11.3.2. Adaptive Servo-Ventilation (ASV)
11.3.3. Positive Airway Pressure (PAP) Devices
11.3.4. Oral Appliances
11.3.5. Oxygen Devices
11.3.6. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Diagnostic Device
11.5.2. By Therapeutic Device
11.5.3. By Country/Sub-region
12. Latin America Sleep Apnea Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Device, 2017–2028
12.2.1. Actigraphy Systems
12.2.2. Polysomnography (PSG) Devices
12.2.3. Respiratory Polygraph
12.2.4. Single-Channel Screening Devices (pulse oximeters)
12.3. Market Value Forecast, by Therapeutic Device, 2017–2028
12.3.1. Airway Clearance Systems
12.3.2. Adaptive Servo-Ventilation (ASV)
12.3.3. Positive Airway Pressure (PAP) Devices
12.3.4. Oral Appliances
12.3.5. Oxygen Devices
12.3.6. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Diagnostic Device
12.5.2. By Therapeutic Device
12.5.3. By Country/Sub-region
13. Middle East & Africa Sleep Apnea Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Device, 2017–2028
13.2.1. Actigraphy Systems
13.2.2. Polysomnography (PSG) Devices
13.2.3. Respiratory Polygraph
13.2.4. Single-Channel Screening Devices (pulse oximeters)
13.3. Market Value Forecast, by Therapeutic Device, 2017–2028
13.3.1. Airway Clearance Systems
13.3.2. Adaptive Servo-Ventilation (ASV)
13.3.3. Positive Airway Pressure (PAP) Devices
13.3.4. Oral Appliances
13.3.5. Oxygen Devices
13.3.6. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Diagnostic Device
13.5.2. By Therapeutic Device
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. CareFusion Corporation
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Fisher & Paykel Healthcare
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. GE Healthcare
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. ImThera Medical, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Philips Healthcare
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. ResMed, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Teleflex, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
List of Tables
Table 1: Market Snapshot: Global Sleep Apnea Devices Market, 2017 and 2028
Table 2: Percentage of Registered Studies by Location
Table 3: Share of Total Global R&D Spending
Table 4: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic, 2021–2028
Table 5: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 6: Global Sleep Apnea Devices Market Revenue (US$ Mn), by Region/country, 2021–2028
Table 7: North America Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028
Table 8: North America Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 9: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028
Table 10: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 11: Europe Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 12: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028
Table 13: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 14: Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 15: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028
Table 16: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 17: Latin America Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 18: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Diagnostic Device, 2021–2028
Table 19: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Therapeutic Device, 2021–2028
Table 20: Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
List of Figures
Figure 1: Market Segmentation: Sleep Apnea Devices Market
Figure 2: Porter’s Five Forces Analysis: Sleep Apnea Devices Market
Figure 3: Value Chain Analysis: Sleep Apnea Devices Market
Figure 4: Market Attractiveness Analysis: Sleep Apnea Devices Market
Figure 5: Global Sleep Apnea Devices Market (US$ Mn), by Diagnostic and Therapeutic Devices, 2017 and 2028
Figure 6: North America Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028
Figure 7: Europe Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028
Figure 8: Asia Pacific Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028
Figure 9: Latin America Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028
Figure 10: Middle East and Africa Sleep Apnea Devices Market Share (Value %), by Region, 2017 and 2028
Figure 11: Competitive Landscape: Sleep Apnea Devices Market
Figure 12: Global Sleep Apnea Devices Market Revenue (US$ Mn), 2021–2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Sleep Apnea Devices Market
